February 13, 2023
EPS Corporation
News Release

EPS Corporation signs agreement with Japan’s MHLW to develop operating
environment and conduct surveys to promote Personal Health Records (PHRs)- EPS will support administrative side of MHLW’s efforts to promote PHRs andenhance the health of Japanese citizens
EPS Corporation (Headquarters: Shinjuku-ku, Tokyo; President and Representative Director: AkiraSASA; hereinafter “EPS”), a leading pharmaceutical development support company, announces thatit has concluded a contract with Japan’s Ministry of Health, Labour and Welfare (MHLW) todevelop the operating environment and conduct studies related to the Personal Health Record(PHR) program being promoted by the MHLW.
As Japan’s birthrate declines, resulting in an increasingly aging society with fewer children and a“super-aged” population, efforts to extend healthy life expectancy are imperative. PHR systems,
which contain health-related personal information and allow individuals and their families toaccurately ascertain the results of their health examinations, medication history, etc., are becoming
rapidly adopted around the world, and such systems are anticipated to play a key role in improving
the health of Japan’s population.
The EPS Group is working toward developing “a New EPS”, including conducting a managementbuyout (MBO) in 2021. We are also working to expand our business into new areas with the aim ofcreating healthier and more fulfilling lives for people through our specialized services. As part ofthis effort, this contract will support the utilization of PHRs to promote Japan's public healthspearheaded by the MHLW.
■ Overview of the Business
The MHLW aims to establish an infrastructure that allows individuals to access to information onpublic health examinations, etc. they received throughout their lifetime via the Mynaportal(Individual Number Portal) and other platforms. Under the agreement, EPS Corporation will revise
the standard format for linking information on municipal health checkups (e.g., cancer screening) todata servers (municipal intermediate servers) linked to Mynaportal and conduct studies on the scopeof impact of the revision, reporting to the MHLW. In addition, we will provide administrative
support to the MHLW in its efforts to promote PHRs.

Benefits of PHRs from Public/Patient Perspective
By utilizing healthcare information in the form of PHRs, we aim to create anenvironment that enables individuals to self-manage their health and change their
behavior accordingly, which is critical for preventive medicine and medical treatment,
as well as enable intervention by health care professionals, and for research and otherrelated purposes.
Purpose of PHR Utilization
1.
2.
3.
4.

To foster healthy behaviors, such as improvement of lifestyle habits
To provide effective and efficient medical care, etc.
To improve the effectiveness of public health measures and projects, and for use
in disasters and other emergencies
To conduct research on public health and medical care

EPS’s Future Vision
We envision that enabling people and patients to utilize their own health and medical information
will help advance health awareness, including preventive measures against illness and presymptomatic disease. Furthermore, we believe that sharing personal information with doctors andother medical practitioners with the consent of the individual will enable people to enjoy better
healthcare and nursing care irrespective of age, gender, disability status, and other factors.
To this end, beginning with this project, we will actively engage in healthcare businesses outside
our traditional domain of drug development, while working to support community medicine andhealth promotion, aiming to “foster healthy and fulfilling lives for all people”.
We will also utilize the insights gained through these efforts to improve drug development
efficiency and promote digital transformation, as well as applying these findings to the healthcare
field in general, in order to continue to make significant contributions to Japan's medical andpharmaceutical development.
About EPS Corporation（https://www.eps.co.jp/en/）
EPS launched its business in 1991 as a CRO to comprehensively support clinical studies with thefocus on clinical trials and PMS. The company proposes new models to satisfy customers’ needs byleveraging its data science expertise and digital technology cultivated through its extensive trackrecord. These proposals are founded in its Trial GATE concept, which acts as the gateway for all
promotion functions of clinical trials.
Contact: EPS Corporation
Public Relations Strategy OfficeE-mail: koho@eps.co.jp